Clinical Trials Directory

Trials / Completed

CompletedNCT02631161

Glass Hybrid Versus Composite Restorations of Non-carious Cervical Lesions

Randomized Controlled Trial on Glass Hybrid Versus Composite Restorations of Non-carious Cervical Lesions

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
88 (actual)
Sponsor
Charite University, Berlin, Germany · Academic / Other
Sex
All
Age
50 Years – 70 Years
Healthy volunteers
Accepted

Summary

A glass hybrid restorative system (EQUIA forte) clinically compared to a composite resin based material (Clearfil SE Bond, Filtek Supreme XT) for the treatment of dental non-carious cervical lesions.

Detailed description

This is a prospective, randomized, monocenter parallel group study on restoration of tooth with non-carious cervical restorations. Each patient receives cervical restoration(s) either with glass hybrid EQUIA forte or with composite resin/adhesive combination Filtek Supreme XT/Clearfil SE Bond in anterior/posterior tooth region. Restorations will be provided by one experienced operator. One of two independent examiners will evaluate the restorations at baseline (1 week after placement), and after 18, and 36 months according to the FDI criteria. Reliability of examination will be assessed on a random sample of 30 restorations.

Conditions

Interventions

TypeNameDescription
OTHEREquia ForteRestoration of cavities with a Glasshybrid material (Equia Forte)
OTHERFiltek Supreme XT/Clearfil SE BondRestoration of cavities with a composite resin based material after placing an adhesive

Timeline

Start date
2015-12-01
Primary completion
2021-02-01
Completion
2021-02-01
First posted
2015-12-16
Last updated
2021-06-18

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02631161. Inclusion in this directory is not an endorsement.